Elizabeth Nabel has become the new director of the National Heart, Lung, and Blood Institute, NIH said last week. Nabel, a board certified cardiologist, joined the NHLBI in 1999 as the institute’s scientific director of clinical research. She holds an MD from Cornell University Medical College.
Melissa Cline has left her post as a bioinformatics scientist at Affymetrix to join Benno Schwikowski’s lab at the Pasteur Institute in Paris, according to BioInform, a GenomeWeb newsletter.
William Rastetter has become non-executive chairman of the board of directors, and John Stuelpnagel was promoted to chief operating officer of Illumina, the San Diego-based company said last week. Rastetter, who has been a member of Illumina’s board since 1998, is the executive chairman of Biogen Idec. Prior to the merger of Idec and Biogen, he was chairman and CEO of Idec Pharmaceuticals. He holds a PhD from Harvard University. Stuelpnagel is a founder of Illumina.
Tina Nova was appointed to the board of directors of Cyntellect, the San Diego-based company said last week. She is the president, CEO, and co-founder of Genoptix. Nova also co-founded Nanogen, where she was chief operating officer and president from 1994 to 2000. Nova holds a PhD in biochemistry from the University of California, Riverside.
Gerald Longa has joined the board of directors of BioStorage Technologies, the Indianapolis, Ind.-based biorepository company said last week. He is the president and co-owner of Terre Haute Medical Laboratory and Pathology Associates of Terre Haute. He is also a clinical associate professor of pathology at the Indiana University School of Medicine.
Ewan Birney of the European Bioinformatics Institute will receive the 2005 Benjamin Franklin Award in Bioinformatics. Bioinformatics.Org makes the award annually to an individual who has "promoted free and open access to the materials and methods used in the scientific field of bioinformatics." The award will be presented at the annual meeting of Bioinformatics.Org in Boston on May 19.
After Kyorin Pharmaceutical of Japan acquired ActivX Biosciences, John Kozarich was appointed chairman and president of ActivX, now a wholly owned subsidiary of Kyorin, as well as chief scientific advisor of Kyorin, ActivX said today. He used to be president and chief R&D officer of ActivX.